Clarius Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Clarius Group's LLY Position: Q4 2025 in Review
Clarius Group reduced its Eli Lilly (LLY) stake by 7.7% in Q4 2025, selling an estimated $418K and leaving 5,202 shares worth $5.59M. The position accounts for 0.32% of the portfolio, ranked #40.
Clarius Group first reported a position in LLY in Q4 2018 and has held it in 29 quarters since. The position peaked at $6.97M in Q2 2025. 4,460 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Clarius Group held 5,202 shares of Eli Lilly worth $5.59M as of Q4 2025.
- Clarius Group sold 437 Eli Lilly shares in Q4 2025, an estimated $418K.
- Eli Lilly made up 0.32% of Clarius Group's portfolio in Q4 2025, its #40 holding.
- Clarius Group first reported a position in Eli Lilly in Q4 2018 and has held it in 29 quarters since.
- Clarius Group's Eli Lilly position peaked at $6.97M in Q2 2025.
- 4,460 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Clarius Group's 13F filing for Q4 2025, filed 14 Jan 2026.